Pharmacoeconomic implications of thromboprophylaxis with new oral anticoagulants after total hip or knee replacement in the USA

Author： Nutescu Edith A  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.4, 2013-03, pp. : 525-534

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Cost-Effectiveness Model Comparing Rivaroxaban and Dabigatran Etexilate with Enoxaparin Sodium as Thromboprophylaxis after Total Hip and Total Knee Replacement in the Irish Healthcare Setting

By McCullagh Laura   Tilson Lesley   Walsh Cathal   Barry Michael  

PharmacoEconomics, Vol. 27, Iss. 10, 2009-10 ,pp. : 829-846

Adis International

Access to resources Recommend Favorite

Incidence of Venous Thromboembolism and Thromboprophylaxis after Total Hip or Knee Arthroplasty

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 38, Iss. 3, 2008-09 ,pp. : 200-204

John Wiley & Sons Inc

Access to resources Recommend Favorite

Value-of-Information Analysis to Reduce Decision Uncertainty Associated with the Choice of Thromboprophylaxis after Total Hip Replacement in the Irish Healthcare Setting

By McCullagh Laura   Walsh Cathal   Barry Michael  

PharmacoEconomics, Vol. 30, Iss. 10, 2012-10 ,pp. : 941-959

Adis International

Access to resources Recommend Favorite

Rivaroxaban: A Review of its Use for the Prophylaxis of Venous Thromboembolism after Total Hip or Knee Replacement Surgery

By Duggan Sean T.  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 1, 2012-02 ,pp. : 57-72

Adis International

Access to resources Recommend Favorite

Dabigatran Etexilate: A Review of its Use for the Prevention of Venous Thromboembolism after Total Hip or Knee Replacement Surgery

By Burness Celeste B.   McKeage Kate  

Drugs, Vol. 72, Iss. 7, 2012-05 ,pp. : 963-986

Adis International

Access to resources Recommend Favorite